Difficulty: Medium
Average Score: 95%
Practice
Tick the group of drugs used as subsidiary medicines in cancer treatment:
Correct answer
D
Rationale
In the context of cancer treatment, it is crucial to understand the role of subsidiary medications that support the main treatment regimen. The correct answer, option D, "All of the above," includes cytoprotectors, bone marrow growth factors, and antimetastatic agents.
Cytoprotectors are drugs that help protect healthy cells from damage during cancer treatment, thereby reducing potential side effects. Bone marrow growth factors stimulate the production of blood cells in the bone marrow, which can be suppressed during certain cancer treatments. Antimetastatic agents are used to inhibit the spread of cancer cells to other parts of the body.
Option A, cytoprotectors, is a group of drugs used to protect healthy cells. Option B, bone marrow growth factors, is essential for maintaining blood cell production. Option C, antimetastatic agents, are crucial in preventing the spread of cancer.
Understanding these subsidiary medications is essential for healthcare professionals involved in cancer treatment to provide comprehensive care and manage potential side effects effectively. By recognizing the role of these drugs, healthcare providers can optimize treatment outcomes and improve the quality of life for cancer patients.
Cytoprotectors are drugs that help protect healthy cells from damage during cancer treatment, thereby reducing potential side effects. Bone marrow growth factors stimulate the production of blood cells in the bone marrow, which can be suppressed during certain cancer treatments. Antimetastatic agents are used to inhibit the spread of cancer cells to other parts of the body.
Option A, cytoprotectors, is a group of drugs used to protect healthy cells. Option B, bone marrow growth factors, is essential for maintaining blood cell production. Option C, antimetastatic agents, are crucial in preventing the spread of cancer.
Understanding these subsidiary medications is essential for healthcare professionals involved in cancer treatment to provide comprehensive care and manage potential side effects effectively. By recognizing the role of these drugs, healthcare providers can optimize treatment outcomes and improve the quality of life for cancer patients.